Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Up 636.6% in February

Straumann Holding AG (OTCMKTS:SAUHY) saw a significant growth in short interest in February. As of February 13th, there was short interest totaling 55,783 shares, a growth of 636.6% from the January 29th total of 7,573 shares. Based on an average trading volume of 282,206 shares, the short-interest ratio is currently 0.2 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average trading volume of 282,206 shares, the short-interest ratio is currently 0.2 days.

Analyst Ratings Changes

SAUHY has been the topic of several research reports. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a report on Monday, December 15th. Citigroup reissued a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Straumann Price Performance

Shares of SAUHY stock traded up $0.23 during mid-day trading on Wednesday, reaching $11.97. The stock had a trading volume of 995,620 shares, compared to its average volume of 122,503. Straumann has a one year low of $10.30 and a one year high of $14.18. The firm’s 50 day simple moving average is $12.19 and its 200 day simple moving average is $11.81.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.